Goldman Sachs Group Inc Kronos Bio, Inc. Transaction History
Goldman Sachs Group Inc
- $605 Billion
- Q3 2024
A detailed history of Goldman Sachs Group Inc transactions in Kronos Bio, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 21,690 shares of KRON stock, worth $21,039. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,690
Previous 17,785
21.96%
Holding current value
$21,039
Previous $22,000
4.55%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding KRON
# of Institutions
56Shares Held
19.8MCall Options Held
9.3KPut Options Held
100-
Vida Ventures Advisors, LLC2.77MShares$2.68 Million3.24% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.05MShares$1.98 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.92MShares$1.87 Million0.0% of portfolio
-
Partners Capital Investment Group, LLP Boston, MA1.61MShares$1.56 Million0.03% of portfolio
-
Alphabet Inc. Mountain View, CA1.44MShares$1.4 Million0.1% of portfolio
About Kronos Bio, Inc.
- Ticker KRON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,769,100
- Market Cap $55.1M
- Description
- Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...